Ernexa Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Ernexa Therapeutics Inc. (ERNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 153.00 thousand shares for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2020-05-20
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-03-31 was 153.00K shares, a 225.53% increase year-over-year.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-09-30 was 1.00K shares, a 300.00% increase year-over-year.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-03-31 was 47.00K shares.
- Ernexa Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-09-30 was 250.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month |
|---|---|---|
| 2020-03-31 | 153.00K shares 10-Q · filed 2020-05-20 | |
| 2019-09-30 | 1.00K shares 10-Q · filed 2019-11-01 | 2.00K shares 10-Q · filed 2019-11-01 |
| 2019-03-31 | 47.00K shares 10-Q · filed 2020-05-20 | |
| 2018-09-30 | 250.00 shares 10-Q · filed 2019-11-01 | 2.00K shares 10-Q · filed 2019-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |